Lexeo Therapeutics LXEO
NASDAQ LXEO
$3.53 -0.09 (-2.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexeo Therapeutics (LXEO) Selling, General & Administrative (2022 - 2026)

Updated

Lexeo Therapeutics (LXEO) posted Selling, General & Administrative of $8.99 million for Q2 2026, down 43.7% from $15.97 million a year earlier but up 35.6% from the prior quarter.

Analysis

Lexeo Therapeutics (LXEO) Selling, General & Administrative (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Lexeo Therapeutics was $28.48 million, down 42.7% year-over-year; for FY2025, it came in at $45.46 million, up 43.5% from FY2024.

  • Annual Selling, General & Administrative has increased for three consecutive years, with a three-year compound annual growth rate of 55.9% (FY2022 to FY2025).
  • In prior years, Lexeo Therapeutics' Selling, General & Administrative was $31.68 million in FY2024 (+105.9%), $15.38 million in FY2023 (+28.2%) and $12 million in FY2022.
  • Quarterly Selling, General & Administrative has run from a low of $2.65 million in Q3 2022 to a high of $16.63 million in Q1 2025 over five years.
  • On a year-over-year basis, Selling, General & Administrative has declined in each of the last four quarters, with growth averaging 37.1% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2024, with growth of 168.3%; the weakest was Q1 2026, with a decline of 60.1%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $6.63 million (Q1 2026), $6.91 million (Q4 2025) and $5.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Lexeo Therapeutics 277.54 Mn 277.54 Mn - 8.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.99 Mn
Mar 31, 2026 6.63 Mn
Dec 31, 2025 6.91 Mn
Sep 30, 2025 5.95 Mn
Jun 30, 2025 15.97 Mn
Mar 31, 2025 16.63 Mn
Dec 31, 2024 9.02 Mn
Sep 30, 2024 8.12 Mn
Jun 30, 2024 6.99 Mn
Mar 31, 2024 7.55 Mn
Dec 31, 2023 6.76 Mn
Sep 30, 2023 3.03 Mn
Jun 30, 2023 2.74 Mn
Mar 31, 2023 2.85 Mn
Dec 31, 2022 3.81 Mn
Sep 30, 2022 2.65 Mn
API Access

Lexeo Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LXEO&period=max&api_key=YOUR_API_KEY